BEN vs ZYME · P/E 36, rev $8.77B vs rev $76.3M
Franklin Resources Inc (BEN) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the BEN and ZYME stock pages for the full models.
Not investment advice.